Valuation Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX 18:09:54 04/09/2026 BST			5-day change	1st Jan Change
549.32 ^USD	-1.55%		+1.62%	+21.42%

09-02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-01	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	141,421	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	22.95%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	130,786	125,635	119,844
Change	-	31.13%	47.8%	4.23%	11.09%	20.63%	-3.94%	-4.61%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	32.9x	26.9x	22.3x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	7.39x	5.86x	4.75x
PEG	-	0.5x	3.51x	2x	-0x	3.1x	1.2x	1.1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	10.7x	9.68x	8.62x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	9.91x	8.6x	7.3x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	30.1x	18.7x	15.4x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	27.8x	19.4x	15.6x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	29.4x	22.2x	16.1x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	3.4%	4.5%	6.22%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	16.96	20.73	25.05
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,193	14,609	16,413
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	4,349	6,703	7,782
EBIT ¹	4,344	4,793	4,375	695.6	5,263	4,700	6,481	7,692
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,306	5,228	6,392
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-10,635	-15,786	-21,577
Reference price ²	219.60	288.78	406.89	402.70	453.36	557.96	557.96	557.96
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,461	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	32.9x	9.91x	30.08x	-.--%	141B
ELI LILLY AND COMPANY	33.01x	11.99x	24.31x	0.6%	1,034B
JOHNSON & JOHNSON	30.97x	-	-	1.93%	671B
ABBVIE INC.	33.21x	7.7x	16x	2.64%	460B
ROCHE HOLDING AG	19.86x	4.73x	11.71x	2.8%	353B
NOVARTIS AG	23.09x	5.93x	14.7x	2.69%	309B
ASTRAZENECA PLC	21.15x	4.34x	12.39x	2.03%	255B
AMGEN INC.	28.09x	7.23x	12.82x	2.27%	240B
NOVO NORDISK A/S	13.44x	4.86x	10.14x	3.75%	207B
GILEAD SCIENCES, INC.	-46.21x	6.66x	25.99x	2.18%	188B
Average	18.95x	7.04x	17.57x	2.09%	385.82B
Weighted average by Cap.	24.69x	8.14x	18.40x	1.86%